In a randomized trial, 73% of relatives offered navigation completed genetic testing within 6 months vs 51% of those who received a family letter.
|Articles|May 4, 2020
Oncology Nursing and the COVID-19 Pandemic
Our recent webinar discussed how COVID-19 is affecting oncology nurses.
Advertisement
Two nurses, Kelley A. Rone, APRN, DNP, and Amber S. Norton RN, BSN, OCN, chatted about how the COVID-19 pandemic is affecting the day-to-day of oncology nurses.
Advertisement
Related to this article
In observation of National PA Week, Moffitt PA Mark Honor details top-of-license nursing collaboration and outpatient end-stage hematology care.
Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events.
Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
FDA approves tucatinib maintenance with trastuzumab and pertuzumab for HER2+ breast cancer based on HER2CLIMB-05.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
2
Multidisciplinary Support for Patients with Metastatic Triple-Negative Breast Cancer
3
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
4
Managing Oral and Ocular Toxicities in Metastatic Triple-Negative Breast Cancer
5